CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,323,510
- in 6 filings, $5.0M under 10b5-1 plans
Net −$7,323,510. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Brege Laura Director | Exercise or conversion | +14,167 | $16.71 | $237K | 29,870 |
| 2026-11-11 | Brege Laura Director | Sale | −10,907 | $94.05 | $1.0M | 18,963 |
| 2026-11-11 | Brege Laura Director | Sale | −3,260 | $94.74 | $309K | 15,703 |
| 2026-11-11 | Brege Laura Director | Exercise or conversion · Stock Option (right to buy) | −14,167 | 0 | ||
| 2026-06-15 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +3,772 | 3,772 | ||
| 2026-06-15 | Brege Laura Director | Grant or award · Deferred Stock Units | +1,980 | 1,980 | ||
| 2025-09-11 | Brege Laura Director | Exercise or conversion | +17,000 | $15.00 | $255K | 32,703 |
| 2025-09-11 | Brege Laura Director | Sale | −15,509 | $74.34 | $1.2M | 17,194 |
| 2025-09-11 | Brege Laura Director | Sale | −1,491 | $75.07 | $112K | 15,703 |
| 2025-09-11 | Brege Laura Director | Exercise or conversion · Stock Option (right to buy) | −17,000 | 0 | ||
| 2025-05-29 | Brege Laura Director | Exercise or conversion | +5,703 | 15,703 | ||
| 2025-05-29 | Brege Laura Director | Exercise or conversion · Restricted Stock Units | −5,703 | 0 | ||
| 2025-05-29 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +6,268 | 6,268 | ||
| 2025-05-29 | Brege Laura Director | Grant or award · Deferred Stock Units | +3,977 | 3,977 | ||
| 2024-06-05 | Brege Laura Director | Grant or award · Stock Option (right to buy) 10b5-1 | +8,779 | 8,779 | ||
| 2024-06-05 | Brege Laura Director | Grant or award · Restricted Stock Units 10b5-1 | +5,703 | 5,703 | ||
| 2023-06-12 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +17,000 | 17,000 | ||
| 2022-06-02 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +17,000 | 17,000 | ||
| 2021-06-04 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +17,000 | 17,000 | ||
| 2020-06-11 | Brege Laura Director | Grant or award · Stock Option (right to buy) | +14,167 | 14,167 |
Page 1 of 2 · 21 trades